Deferred Tax Assets, Gross of Anixa Biosciences Inc from 31 Oct 2012 to 31 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Anixa Biosciences Inc quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Oct 2012 to 31 Oct 2024.
  • Anixa Biosciences Inc Deferred Tax Assets, Gross for the quarter ending 31 Oct 2024 was $37,753,000,000.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $37,753,000,000* +$37,718,498,000 31 Oct 2024 10-K 10 Jan 2025 2024 FY
Q3 2023 $34,502,000 +$4,900,000 +17% 31 Oct 2023 10-K 10 Jan 2025 2024 FY
Q3 2022 $29,602,000 +$1,321,000 +4.7% 31 Oct 2022 10-K 16 Jan 2024 2023 FY
Q3 2021 $28,281,000 -$475,000 -1.7% 31 Oct 2021 10-K 04 Jan 2023 2022 FY
Q3 2020 $28,756,000 +$396,000 +1.4% 31 Oct 2020 10-K 04 Jan 2022 2022 FY
Q3 2019 $28,360,000 +$1,943,000 +7.4% 31 Oct 2019 10-K 07 Jan 2021 2020 FY
Q3 2018 $26,417,000 +$2,990,000 +13% 31 Oct 2018 10-K 09 Jan 2020 2019 FY
Q3 2017 $23,427,000 -$16,886,000 -42% 31 Oct 2017 10-K 11 Jan 2019 2018 FY
Q3 2016 $40,313,000 +$1,765,000 +4.6% 31 Oct 2016 10-K 09 Jan 2018 2017 FY
Q3 2015 $38,548,000 +$888,000 +2.4% 31 Oct 2015 10-K 08 Dec 2016 2016 FY
Q3 2014 $37,660,000 +$7,783,000 +26% 31 Oct 2014 10-K 23 Dec 2015 2015 FY
Q3 2013 $29,877,000 +$2,486,000 +9.1% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q3 2012 $27,391,000 31 Oct 2012 10-K/A 17 Jan 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.